Cannabis Report
Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

How about the wording in the CDA agreement

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
djs7 Member Profile
 
Followed By 5
Posts 419
Boards Moderated 0
Alias Born 08/29/14
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/29/2018 2:11:50 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/29/2018 7:24:52 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2018 4:14:20 PM
Traders News Issues Research on High Growth Canna and Pharma Stocks InvestorsHub NewsWire - 4/25/2018 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/16/2018 1:18:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2018 3:04:31 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/7/2018 4:59:15 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/11/2018 4:35:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/27/2017 3:08:40 PM
Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) Edgar (US Regulatory) - 11/13/2017 10:03:05 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2017 4:04:57 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/22/2017 6:02:17 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/11/2017 12:47:10 PM
Annual Report (10-k) Edgar (US Regulatory) - 9/11/2017 6:04:38 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/11/2017 6:04:37 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/6/2017 6:27:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/6/2017 6:24:45 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/8/2017 4:18:08 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 8/8/2017 4:17:33 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 8/8/2017 4:17:00 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 8/8/2017 4:16:36 PM
djs7   Friday, 01/12/18 03:45:06 PM
Re: Rdunn88 post# 212643
Post # of 234667 
How about the wording in the CDA agreement that could say

"At any time, the interested parties may request a delay or postponement of the interim analysis
while intermittent case reports and analysis are shared from the sponsor IPIX."


As for the 2Q interim analysis, remember the trial originally had a completion date of July 2017. It did not finish til end of December 2017. The delays in enrollment may have pushed an intended Q2 interim analysis to Q3. By such time, a majority of patients had completed at least 6 weeks therapy.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist